A previous study using euglycemic-hyperinsulinemic glucose clamps in patients with type II diabetes demonstrated that in the skeletal muscle of the diabetes group, the HO-1 mRNA expression levels were 55% lower than those in the control group prior to clamp placement; however, the levels increased by 70-fold following clamp placement. This evidence concerns the gene HMOX1 and type 2 diabetes mellitus.